CD34 <sup>+</sup> progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg <sup>null</sup> mice
Jolien M.R. Van der Meer(Sanquin), Harry Dolstra(Radboud University Nijmegen), Nicolaas Schaap(Radboud University Nijmegen), Malou C. Vermeulen(Radboud University Nijmegen), Joop H. Jansen(Radboud University Nijmegen), Janne de Klein(Radboud University Nijmegen), Alexander C. Geerlings(Radboud University Nijmegen), Jurgen P. Moonen(Radboud University Medical Center), Petronella B. Ottevanger(Radboud University Nijmegen), Willemijn Hobo(Maastricht University Medical Centre), Jolanda Brummelman(Radboud University Nijmegen), Paul K.J.D. de Jonge(Radboud University Nijmegen), Janneke S. Hoogstad‐van Evert(Radboud University Nijmegen), Ralph J. A. Maas(Radboud University Nijmegen), Anniek B. van der Waart(Radboud University Nijmegen)
Cited by 19
Related Papers
Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized <i>WT1</i> Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
|Journal of Clinical Oncology|2009|434
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
|Bone Marrow Transplantation|2022|378